ZIOP · Categories · Form 4
ZIOP - SEC Form 4 insider transactions
ZIOPHARM Oncology Inc (ZIOP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ZIOP
- SEC Form 4: De Groot Eleanor sold $25,568 worth of shares (20,132 units at $1.27) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 237,106 units (tax withholding)4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4 filed by Lackey Melinda4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Boyle Kevin S. Sr. bought $14,000 worth of shares (10,000 units at $1.40), increasing direct ownership by 1% to 885,000 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Vieser Jaime bought $191,000 worth of shares (100,000 units at $1.91), increasing direct ownership by 17% to 705,321 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Hagen Heidi bought $41,835 worth of Common Stock (23,770 units at $1.76), increasing direct ownership by 19% to 145,889 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Weis Holger bought $91,500 worth of Common Stock (50,000 units at $1.83), increasing direct ownership by 71% to 120,167 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Postma Robert W bought $129,750 worth of Common Stock (75,000 units at $1.73), increasing direct ownership by 2% to 1,201,870 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Huang James bought $171,000 worth of Common Stock (100,000 units at $1.71), increasing direct ownership by 1,200% to 108,333 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Boyle Kevin S. Sr. was granted 875,000 units of Common Stock4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Baffa Raffaele was granted 80,645 units of Common Stock, increasing direct ownership by 40% to 280,645 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Weis Holger was granted 4,167 units of Common Stock, increasing direct ownership by 6% to 70,167 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Vieser Jaime was granted 4,167 units of Common Stock, increasing direct ownership by 0.69% to 605,321 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Thistle Mary was granted 5,000 units of Common Stock4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Postma Robert W was granted 2,500 units of Common Stock, increasing direct ownership by 0.21% to 1,181,362 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Huang James was granted 8,333 units of Common Stock4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: BUCHI J KEVIN was granted 4,167 units of Common Stock4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Bowden Christopher was granted 4,167 units of Common Stock4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Jill Buck was granted 31,500 units of Common Stock, increasing direct ownership by 16% to 231,016 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Robert Hadfield was granted 43,500 units of Common Stock, increasing direct ownership by 33% to 176,819 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Heidi Hagen was granted 90,000 units of Common Stock, increasing direct ownership by 280% to 122,119 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)
- SEC Form 4: Eleanor Groot De was granted 50,825 units of Common Stock, increasing direct ownership by 25% to 257,238 units4 - ZIOPHARM ONCOLOGY INC (0001107421) (Issuer)